Group Leader
Anthony J Gill AM is Professor of Surgical Pathology at the University of Sydney and a senior staff specialist in anatomical pathology at the Royal North Shore Hospital. Anthony has a keen interest in the application of innovative diagnostic pathology techniques in translational cancer research with particular emphasis on cancer biomarker discovery and validation.
​
He has published extensively in hereditary cancer syndromes as well as endocrine,
gastrointestinal and hepatobiliary pathology, and is an internationally recognised expert on hereditary cancers which arise due to defects in oxidative respiration (so called “SDH deficient” neoplasms).
Anthony is a Chief Investigator at the Kolling Institute and a member of the executive board of the Sydney Vital Translational Cancer Research Unit. He is also the current chairman and a founding member of the Australian Pancreatic Cancer Genome Initiative based at the Garvan Institute.
​
In addition to over 500 original research publications, Anthony is a standing member of the Editorial Board for the 5th edition of the WHO blue book series.
Group Members
Adele Clarkson is a senior scientist with over 15 years of experience in diagnostic immunohistochemical analytical techniques. She runs a busy diagnostic immunohistochemistry laboratory at Pathology North, Royal North Shore Hospital, a tertiary level healthcare facility which provides diagnostic services for the management of complex malignancies including haemotolymphoid and solid organ neoplasms. Adele has expertise in the optimisation of novel antibodies for research and diagnostic immunohistochemistry on formalin fixed paraffin embedded (FFPE) tissue.
Loretta Sioson uses the Veridiam tissue arrayer to create tissue micro-arrays containing 1mm diameter cores. She works with diverse tissue types, including colon, brain, thyroid, breast and lung.
Angela Chou is a fellow of the Royal College of Pathologists of Australasia. She divides her time between a busy clinical practice at the Royal North Shore Hospital in Sydney and research work at the University of Sydney where she is Associate Professor. Angela's research interest lies in the translational application of molecular techniques in cancer diagnosis. She is also affiliated with the Australian Pancreatic Cancer Genome Initiative providing specialist input in hepatobiliary and upper gastrointestinal pathology.
​